SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Cruz C.
(Autor externo)

Obras con ISBN:2
Documentos en revistas:93
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:
1.- Modeling and simulation of a magnonic gas sensor to detected diseases in human breath (2021)
 
2.- Study of magnetoelastic resonance for chemical sensors: Ribbons vs microwires (2021)
 
Documentos en revistas:
1.- Rapid and reliable detection of high uric acid concentrations (Gout disease) using piezoelectric signals (2026)
 
2.- Influence of Annealing Temperature on the Phase Transformations of Composite Electroless Ni-P-X, X=SiC, Al2 O3 Coatings (2025)
 
3.- A second update on mapping the human genetic architecture of COVID-19 (2023)
 
4.- Carbon SH-SAW-Based Electronic Nose to Discriminate and Classify Sub-ppm NO2 (2022)
 
5.- Eco-Friendly Disposable WS2 Paper Sensor for Sub-ppm NO2 Detection at Room Temperature (2022)
 
6.- Beyond words: From jaguar population trends to conservation and public policy in Mexico (2021)
 
7.- A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial (2021)
 
8.- Global patterns of raptor distribution and protected areas optimal selection to reduce the extinction crises (2021)
 
9.- Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis (2021)
 
10.- Urinary soluble CD163: A novel noninvasive biomarker of activity for lupus nephritis (2020)
 
11.- Angiotensin II receptor agonist antibodies are associated with microvascular damage in lupus nephritis (2020)
 
12.- Epidemiology of intra-abdominal infection and sepsis in critically ill patients: ?AbSeS?, a multinational observational cohort study and ESICM Trials Group Project (2019)
 
13.- Interaction of He 8 with Pb 208 at near-barrier energies: He 4 and He 6 production (2018)
 
14.- Structural behavior of the General Archive of the Nation (AGN) building, Mexico (2018)
 
15.- Biomarkers associated with vascular calcification in peritoneal dialysis (2016)
 
16.- Creencias y normas en México: Una actualización del estudio de las premisas psico-socio-culturales (2015)
 
17.- Near barrier scattering of 8He on 208Pb (2014)
 
18.- Elastic scattering of 8He + 208Pb at 22 MeV (2013)
 
19.- Scattering of 8He on 208Pb at 22 MeV (2013)
 
20.- Scattering of 8He on 208Pb at energies around the coulomb barrier (2012)
 
21.- Fusion of 8He with 206Pb around Coulomb barrier energies (2011)
 
22.- Diferencias de sexo en la prevalencia y severidad de trastornos psiquiátricos en adolescentes de la Ciudad de México (2009)
 
23.- Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats (2007)
 
24.- Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity (2007)
 
25.- Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone (2007)
 
26.- Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity (2005)
 
27.- PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage (2005)
 
28.- Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside (2004)
 
29.- Serum activity/concentration profiles of a sustained-released formulation of sulphathiazole-trimethoprim (2·5:1) in calves (2004)
 
30.- Serotonin transporter gene and obese females with impulsivity (2002)
 
31.- A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome (2002)
 
32.- Novelty seeking extreme phenotypes in ocd carriers: The low transcription allele of the MAO-A/uVNTR polymorphism (2001)
 
33.- Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder (2001)
 
34.- Dopamine D4 receptor (DRD4) gene polymorphism in the first psychotic episode (2001)
 
35.- Lack of association of apolipoprotein E polymorphism in obsessive-compulsive disorder (2001)
 
36.- Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder (2001)
 
37.- Reproductive function in male rats with chronic nephrosis (1999)
 
38.- Opioid peptide systems following a subconvulsant dose of pentylenetetrazol in rats (1999)
 
39.- Understanding the genetic basis of obsessive-compulsive disorder (1999)
 
40.- Allelic association study between collagen type I (COLIA1 and COLIA2) polymorphisms and alcohol liver disease [Estudio de la asociacion alelica entre los polimorfismos de los genes de colagena tipo I (COLIA1 y COLIA2) y dano hepatico de tipo (1998)
 
41.- Activacion del sistema de los opiodes endogenos por dosis subconvulsivantes de metrazol (1998)
 
42.- A higher frequency of a low activity-related allele of the MAO-A gene in females with obsessive-compulsive disorder (1998)
 
43.- Ascites fluid of nephrotic rats: Sodium dodecyl sulphate-polyacrylamide gel electrophoresis protein pattern and the renin-angiotensin system (1998)
 
44.- Induction of clusterin in tubules of nephrotic rats (1998)
 
45.- Dopamine D2 and D4 receptor genes distinguish the clinical presence of tics in obsessive-compulsive disorder [Los genes de los receptores a dopamina D2 y D4 distinguen la presencia clínica de tics en el trastorno obsesivo-compulsivo.] (1998)
 
46.- Molecular genotypes of dopamine and serotonin metabolism-related genes in major depression (1998)
 
47.- Clinical variables, molecular genotypes and personality as predictors antidepressant response. A parallel study of a clinical trial of fluvoxamine vs. imipramine [Variables clinicas, geneticas y de personalidad como predictores de respuesta (1998)
 
48.- Transient alteration of the reproductive function in nephrotic rats (1997)
 
49.- Time relationships between portal hypertension, decrease in sodium excretion, and activation of the renin angiotensin system in rats with experimental biliary cirrhosis [Cronología de hipertensión portal, disminución de excreción de sodi (1997)
 
50.- Reduced kidney branched chain aminotransferase expression in puromycin aminonucleoside-induced nephrotic syndrome (1997)
 
51.- Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics (1997)
 
52.- Biochemical bone markers, bone mineral content, and bone mineral density in rats with experimental nephrotic syndrome (1997)
 
53.- Time course analysis of serum and urinary proteins by SDS-PAGE in experimental nephrotic syndrome (1996)
 
54.- DRD2, DRD3 and 5HT2A receptor genes polymorphisms in Obsessive-Compulsive Disorder (1996)
 
55.- Homologous conditioned medium enhances expression of TRH in hypothalamic neurons in primary culture (1995)
 
56.- Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats (1995)
 
57.- Molecular analysis of the phenylalanine hydroxylase gene in Mexican phenylketonuric patients (1995)
 
58.- Pituitary-ovarian dysfunction in rats with induced nephrotic syndrome (1995)
 
59.- Angiotensin I converting enzyme in glycerol-induced acute renal failure in rats (1995)
 
60.- Angiotensin I converting enzyme activity in uranyl nitrate induced acute renal failure in rats (1995)
 
61.- Urinary angiotensin I-converting enzyme activity is increased in experimental acute renal failure (1995)
 
62.- The dopamine d2 receptor gene TaqI a1 polymorphism and alcoholism in a Mexican population (1995)
 
63.- Abnormalities of coagulation in experimental nephrotic syndrome (1994)
 
64.- Role of the renin-angiotensin system in arterial hypertension secondary to acute unilateral urinary obstruction (1994)
 
65.- Copper and zinc metabolism in aminonucleoside-induced nephrotic syndrome (1994)
 
66.- Effect of chloride and diamide on serum angiotensin i-converting enzyme activity from eight mammalian species (1993)
 
67.- Angiotensin i-converting enzyme activity in rats with carbon tetrachloride-induced acute renal failure (1993)
 
68.- Electrophoretic analysis of serum and urinary proteins in rats with aminonucleoside-induced nephrotic syndrome (1993)
 
69.- Effect of a short-term captopril treatment on serum and tissue angiotensin I-converting enzyme activity from four mammalian species. Differences using diamide in the in vitro assay (1993)
 
70.- Circulating levels of active, total and inactive renin (prorenin), angiotensin I and angiotensinogen in carbon tetrachloride-treated rats (1993)
 
71.- Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome (1992)
 
72.- Health technology in Mexico [La tecnología de la salud en México.] (1992)
 
73.- Role of angiotensin II in the antinatriuresis that follows acute volume depletion (1992)
 
74.- Captopril magnifies the increase in angiotensin I-converting enzyme activity in rats with aminonucleoside nephrosis (1992)
 
75.- Effect of captopril on urinary excretion of renin and angiotensinogen in aminonucleoside nephrosis (1992)
 
76.- Serum and urinary ceruloplasmin in experimental nephrotic syndrome (1992)
 
77.- Neuronal localization of pyroglutamate aminopeptidase II in primary cultures of fetal mouse brain (1991)
 
78.- Urinary excretion of renin and angiotensinogen in nephrotic rats (1991)
 
79.- Angiotensin I-converting enzyme activity in puromycin aminonucleoside-nephrotic syndrome (1990)
 
80.- Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuris, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention (1990)
 
81.- Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone (1990)
 
82.- Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention (1990)
 
83.- Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain (1990)
 
84.- Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats (1990)
 
85.- Lack of correlation between human serum angiotensin converting enzyme activity and the renin-angiotensin-aldosterone system (1990)
 
86.- MICETOMA QUISTICO POR MADURELLE GRISEA (1990)
 
87.- Physiological relevance of pyroglutamate aminopeptidase II (1989)
 
88.- Intracellular messengers in the regulation of renin secretion [Mensajeros intracelulares en la regulación de la secreción de renina.] (1989)
 
89.- The narrow specificity pyroglutamate amino peptidase degrading TRH in rat brain is an ectoenzyme (1988)
 
90.- Obtaining antibodies against angiotensin II [Obtención de anticuerpos contra angiotensina II.] (1988)
 
91.- Angiotensin II levels in rats subjected to stimulation of the renin-angiotensin system [Niveles de angiotensina II en ratas sometídas a estimulos del sistema renina-angiotensina.] (1988)
 
92.- Polyclonal antibody production for the quantification of angiotensin I decapeptide by radioimmunoanalysis [Producción de anticuerpos policlonales para la cuantificación del decapéptido angiotensina I por radioinmunoanálisis.] (1988)
 
93.- A novel synthesis of mixed esters of phosphoric acid from alkyl o-hydroxyphenyl hydrogen phosphates (1971)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.